Cargando…
Distinctive microRNA expression in early stage nasopharyngeal carcinoma patients
The goal of this study was to investigate microRNAs (miRs) expression at different stages of nasopharyngeal carcinoma (NPC). MiR expression profiling at various stages of NPC was performed by miR array and further verified using quantitative real‐time RT‐PCR. Pathway enrichment analysis was carried...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134390/ https://www.ncbi.nlm.nih.gov/pubmed/27489139 http://dx.doi.org/10.1111/jcmm.12906 |
_version_ | 1782471447520739328 |
---|---|
author | Li, Shuna Hang, Lihua Ma, Yongming Wu, Chaoyang |
author_facet | Li, Shuna Hang, Lihua Ma, Yongming Wu, Chaoyang |
author_sort | Li, Shuna |
collection | PubMed |
description | The goal of this study was to investigate microRNAs (miRs) expression at different stages of nasopharyngeal carcinoma (NPC). MiR expression profiling at various stages of NPC was performed by miR array and further verified using quantitative real‐time RT‐PCR. Pathway enrichment analysis was carried out to identify the functional pathways regulated by the miRs. The expression of a selected group of identified miRs was verified in stage I NPC by in situ hybridization (ISH). A total of 449 miRs were identified with significantly different expressions between NPC tissues and normal pharyngeal tissues. Eighty‐four miRs were dysregulated only in stage I NPC, among which 45 miRs were up‐regulated and the other 39 were down‐regulated. Pathway enrichment assay revleaed that three significantly down‐regulated and three significantly up‐regulated miRs involved in 12 pathways associating with tumour formation and progression. Quantitative RT‐PCR confirmed the miR array result. In addition, the low expression levels of hsa‐miR‐4324, hsa‐miR‐203a and hsa‐miR‐199b‐5p were further validated in stage I NPC by ISH. This present study identifed the miR signature in stage I NPC, providing the basis for early detection and treatment of NPC. |
format | Online Article Text |
id | pubmed-5134390 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-51343902016-12-15 Distinctive microRNA expression in early stage nasopharyngeal carcinoma patients Li, Shuna Hang, Lihua Ma, Yongming Wu, Chaoyang J Cell Mol Med Original Articles The goal of this study was to investigate microRNAs (miRs) expression at different stages of nasopharyngeal carcinoma (NPC). MiR expression profiling at various stages of NPC was performed by miR array and further verified using quantitative real‐time RT‐PCR. Pathway enrichment analysis was carried out to identify the functional pathways regulated by the miRs. The expression of a selected group of identified miRs was verified in stage I NPC by in situ hybridization (ISH). A total of 449 miRs were identified with significantly different expressions between NPC tissues and normal pharyngeal tissues. Eighty‐four miRs were dysregulated only in stage I NPC, among which 45 miRs were up‐regulated and the other 39 were down‐regulated. Pathway enrichment assay revleaed that three significantly down‐regulated and three significantly up‐regulated miRs involved in 12 pathways associating with tumour formation and progression. Quantitative RT‐PCR confirmed the miR array result. In addition, the low expression levels of hsa‐miR‐4324, hsa‐miR‐203a and hsa‐miR‐199b‐5p were further validated in stage I NPC by ISH. This present study identifed the miR signature in stage I NPC, providing the basis for early detection and treatment of NPC. John Wiley and Sons Inc. 2016-08-04 2016-12 /pmc/articles/PMC5134390/ /pubmed/27489139 http://dx.doi.org/10.1111/jcmm.12906 Text en © 2016 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Li, Shuna Hang, Lihua Ma, Yongming Wu, Chaoyang Distinctive microRNA expression in early stage nasopharyngeal carcinoma patients |
title | Distinctive microRNA expression in early stage nasopharyngeal carcinoma patients |
title_full | Distinctive microRNA expression in early stage nasopharyngeal carcinoma patients |
title_fullStr | Distinctive microRNA expression in early stage nasopharyngeal carcinoma patients |
title_full_unstemmed | Distinctive microRNA expression in early stage nasopharyngeal carcinoma patients |
title_short | Distinctive microRNA expression in early stage nasopharyngeal carcinoma patients |
title_sort | distinctive microrna expression in early stage nasopharyngeal carcinoma patients |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134390/ https://www.ncbi.nlm.nih.gov/pubmed/27489139 http://dx.doi.org/10.1111/jcmm.12906 |
work_keys_str_mv | AT lishuna distinctivemicrornaexpressioninearlystagenasopharyngealcarcinomapatients AT hanglihua distinctivemicrornaexpressioninearlystagenasopharyngealcarcinomapatients AT mayongming distinctivemicrornaexpressioninearlystagenasopharyngealcarcinomapatients AT wuchaoyang distinctivemicrornaexpressioninearlystagenasopharyngealcarcinomapatients |